Clinical Trial Update: Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer

View source ↗

Summary

The clinical trial evaluating the impact of chemotherapy on gamma-delta T cells in epithelial ovarian cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Snippet

Sponsor: Rennes University Hospital | Conditions: Ovarian Cancer | Status: WITHDRAWN